• Explore /
  • Poster
  • / A phase II trial of low-dose nab-paclitaxel for patients with previously treated or recurrent advanced gastric cancer (OGSG1302).

A phase II trial of low-dose nab-paclitaxel for patients with previously treated or recurrent advanced gastric cancer (OGSG1302).

Abstract Poster

Authors

null

Masashi Hirota

Department of Surgery, Toyonaka Municipal Hospital, Toyonaka City, Osaka, Japan

Masashi Hirota , Shigeyuki Tamura , Hirokazu Taniguchi , Atsushi Takeno , Hiroshi Imamura , Junya Fujita , Jin Matsuyama , Yutaka Kimura , Junji Kawada , Motohiro Hirao , Kazuhiro Nishikawa , Kazumasa Fujitani , Yukinori Kurokawa , Daisuke Sakai , Hisato Kawakami , Toshio Shimokawa , Taroh Satoh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

UMIN 000012701

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 350)

Abstract #

350

Poster Bd #

D5

Abstract Disclosures

Similar Posters

First Author: Yoshihiko Nakamoto

First Author: Yoshinari Mochizuki

First Author: Yasuyuki Kawamoto

First Author: Hongjae Chon